Vaishali Pharma Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.030x

Vaishali Pharma Limited cash flow conversion efficiency. Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has a cash flow conversion efficiency ratio of 0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs20.46 Million ≈ $221.23K USD) by net assets (Rs673.82 Million ≈ $7.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vaishali Pharma Limited (2013–2026)

Cash flow conversion efficiency of Vaishali Pharma Limited from 2013 to 2026. This chart illustrates how Vaishali Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Vaishali Pharma Limited for real-time trading data and today's change.

Vaishali Pharma Limited Cash Flow Conversion Ratio Explained

Vaishali Pharma Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vaishali Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vaishali Pharma Limited ranked by their cash flow conversion efficiency. Also see Vaishali Pharma Limited stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tian An Australia Ltd AU:TIA	0.083x
VL E-Governance & IT Solutions Limited NSE:VLEGOV	N/A
Investcorp Credit Management BDC Inc NASDAQ:ICMB	0.187x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x
Mainz Biomed BV NASDAQ:MYNZ	-6.957x
Intanwijaya Internasional Tbk JK:INCI	0.079x
Cuscapi Berhad KLSE:0051	0.081x
Nala Digital Commerce Ltd TA:NALA	-0.080x

Annual Cash Flow Conversion Efficiency for Vaishali Pharma Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Vaishali Pharma Limited from 2013 to 2026. Review how much free cash does Vaishali Pharma Limited generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs691.15 Million ≈ $7.47 Million	Rs4.36 Million ≈ $47.12K	0.006x	+102.27%
2025-03-31	Rs649.16 Million ≈ $7.02 Million	Rs-180.38 Million ≈ $-1.95 Million	-0.278x	-1575.62%
2024-03-31	Rs428.39 Million ≈ $4.63 Million	Rs8.07 Million ≈ $87.24K	0.019x	-29.31%
2023-03-31	Rs405.31 Million ≈ $4.38 Million	Rs10.80 Million ≈ $116.77K	0.027x	-46.76%
2022-03-31	Rs263.54 Million ≈ $2.85 Million	Rs13.19 Million ≈ $142.60K	0.050x	-44.23%
2021-03-31	Rs224.19 Million ≈ $2.42 Million	Rs20.11 Million ≈ $217.49K	0.090x	-40.41%
2020-03-31	Rs213.81 Million ≈ $2.31 Million	Rs32.19 Million ≈ $348.11K	0.151x	+13.11%
2019-03-31	Rs213.99 Million ≈ $2.31 Million	Rs28.48 Million ≈ $308.01K	0.133x	+128.99%
2018-03-31	Rs206.02 Million ≈ $2.23 Million	Rs-94.60 Million ≈ $-1.02 Million	-0.459x	-308.54%
2017-03-31	Rs38.69 Million ≈ $418.36K	Rs8.52 Million ≈ $92.12K	0.220x	-84.38%
2016-03-31	Rs32.54 Million ≈ $351.88K	Rs45.88 Million ≈ $496.16K	1.410x	+222.75%
2015-03-31	Rs32.35 Million ≈ $349.85K	Rs-37.16 Million ≈ $-401.89K	-1.149x	+49.84%
2014-03-31	Rs30.74 Million ≈ $332.40K	Rs-70.40 Million ≈ $-761.32K	-2.290x	-267.26%
2013-03-31	Rs27.73 Million ≈ $299.89K	Rs37.97 Million ≈ $410.64K	1.369x	--

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$9.50 Million

Rs878.01 Million INR

Market Cap Rank

#27052 Global

#1504 in India

Share Price

Rs6.73

Change (1 day)

-0.88%

52-Week Range

Rs4.88 - Rs9.84

All Time High

Rs42.57